Details for New Drug Application (NDA): 074137
✉ Email this page to a colleague
The generic ingredient in BUPRENORPHINE HYDROCHLORIDE is buprenorphine hydrochloride; naloxone hydrochloride. There are twenty-nine drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the buprenorphine hydrochloride; naloxone hydrochloride profile page.
Summary for 074137
Tradename: | BUPRENORPHINE HYDROCHLORIDE |
Applicant: | Hospira |
Ingredient: | buprenorphine hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 074137
Mechanism of Action | Partial Opioid Agonists |
Suppliers and Packaging for NDA: 074137
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
BUPRENORPHINE HYDROCHLORIDE | buprenorphine hydrochloride | INJECTABLE;INJECTION | 074137 | ANDA | Hospira, Inc. | 0409-2012 | 0409-2012-32 | 10 CARTRIDGE in 1 CARTON (0409-2012-32) / 1 mL in 1 CARTRIDGE (0409-2012-03) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 0.3MG BASE/ML | ||||
Approval Date: | Jun 3, 1996 | TE: | AP | RLD: | No |
Complete Access Available with Subscription